These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19458681)

  • 1. Alzheimer's theory makes a splash.
    Schnabel J
    Nature; 2009 May; 459(7245):310. PubMed ID: 19458681
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease.
    DeMattos RB; Bales KR; Cummins DJ; Dodart JC; Paul SM; Holtzman DM
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8850-5. PubMed ID: 11438712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging Alzheimer's amyloid.
    Selkoe DJ
    Nat Biotechnol; 2000 Aug; 18(8):823-4. PubMed ID: 10932146
    [No Abstract]   [Full Text] [Related]  

  • 4. Alzheimer's disease-type brain abnormalities in animal models.
    Price DL; Martin LJ; Sisodia SS; Walker LC; Cork LC
    Prog Clin Biol Res; 1992; 379():271-87. PubMed ID: 1409750
    [No Abstract]   [Full Text] [Related]  

  • 5. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.
    Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O
    Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterisation of the novel amyloid-beta peptide-induced protein p17.
    Nehar S; Mishra M; Heese K
    FEBS Lett; 2009 Oct; 583(19):3247-53. PubMed ID: 19755123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease: intraneuronal alterations precede insoluble amyloid-beta formation.
    Braak H; Del Tredici K
    Neurobiol Aging; 2004 Jul; 25(6):713-8; discussion 743-6. PubMed ID: 15165692
    [No Abstract]   [Full Text] [Related]  

  • 8. Amyloid beta peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology.
    Kar S; Quirion R
    Prog Brain Res; 2004; 145():261-74. PubMed ID: 14650921
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell biology: infectious Alzheimer's disease?
    Riek R
    Nature; 2006 Nov; 444(7118):429-31. PubMed ID: 17122841
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuropathology: Alzheimer's in real time.
    Masliah E
    Nature; 2008 Feb; 451(7179):638-9. PubMed ID: 18256653
    [No Abstract]   [Full Text] [Related]  

  • 11. Isomerization of the Asp7 residue results in zinc-induced oligomerization of Alzheimer's disease amyloid beta(1-16) peptide.
    Tsvetkov PO; Popov IA; Nikolaev EN; Archakov AI; Makarov AA; Kozin SA
    Chembiochem; 2008 Jul; 9(10):1564-7. PubMed ID: 18506864
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of Alzheimer's disease amyloid plaque load in transgenic mice by D3, A D-enantiomeric peptide identified by mirror image phage display.
    van Groen T; Wiesehan K; Funke SA; Kadish I; Nagel-Steger L; Willbold D
    ChemMedChem; 2008 Dec; 3(12):1848-52. PubMed ID: 19016284
    [No Abstract]   [Full Text] [Related]  

  • 13. Abeta(25-35) as proxyholder for amyloidogenic peptides: in vivo evidence.
    Gulyaeva NV; Stepanichev MY
    Exp Neurol; 2010 Mar; 222(1):6-9. PubMed ID: 20043907
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
    Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM
    Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid hypothesis of Alzheimer's rides high--for now.
    Schehr RS
    Nat Biotechnol; 1997 Jan; 15(1):19-20. PubMed ID: 9035100
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmin deficiency does not alter endogenous murine amyloid beta levels in mice.
    Tucker HM; Simpson J; Kihiko-Ehmann M; Younkin LH; McGillis JP; Younkin SG; Degen JL; Estus S
    Neurosci Lett; 2004 Sep; 368(3):285-9. PubMed ID: 15364412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gangliosides determine the amyloid pathology of Alzheimer's disease.
    Oikawa N; Yamaguchi H; Ogino K; Taki T; Yuyama K; Yamamoto N; Shin RW; Furukawa K; Yanagisawa K
    Neuroreport; 2009 Aug; 20(12):1043-6. PubMed ID: 19590389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of plasma beta-amyloid level by glucose loading in Alzheimer mouse models.
    Takeda S; Sato N; Uchio-Yamada K; Sawada K; Kunieda T; Takeuchi D; Kurinami H; Shinohara M; Rakugi H; Morishita R
    Biochem Biophys Res Commun; 2009 Jul; 385(2):193-7. PubMed ID: 19450564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of cystatins in Alzheimer's disease.
    Zerovnik E
    Bioessays; 2009 Jun; 31(6):597-9. PubMed ID: 19382231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
    J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.